What a new FDA commissioner could mean for clinical research

What a new FDA commissioner could mean for clinical research

Submitted by admin on April 2, 2019 - 11:29pm
Source: 
Mass Device
News Tags: 
R&D
FDA
510(k)
Headline: 
What a new FDA commissioner could mean for clinical research
snippet: 

With the resignation of FDA Commissioner Scott Gottlieb taking effect this month, many clinical research professionals are wondering how this could impact their drug and device trials.

Do Not Allow Advertisers to Use My Personal information